Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer. - Lin SH; Lin HY; Verma V; Xu-Welliver M; Thall PF; Yao L; Kim PY; Gombos DS; Kawedia JD; Komaki R; Gomez DR; Nguyen QN; et al. (Cancer treatment and research communications, 2022)